Oliver Schwardt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Oliver Schwardt has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Beat Ernst
Department of Pharmaceutical Sciences, Group Molecular Pharmacy, Pharmazentrum, University of Basel, Klingelbergstrasse 50, Basel CH-4056, Switzerland
5 shared publications - Xiaohua Jiang
Department of Pharmaceutical Sciences, Group Molecular Pharmacy, Pharmazentrum University of Basel Basel Switzerland
2 shared publications - Andrew J. Benie
Department of Biophysics & Formulation 1, Novo Nordisk A/S, Måløv, Denmark
1 shared publication - Anirban Bhunia
Department of Chemical Sciences, Bose Institute, Unified Academic Campus, Salt Lake, Sector V, Kolkata 700091, India
1 shared publication Benedetta Girardi
Molecular Pharmacy Group Department of Pharmaceutical Sciences University of Basel Klingelbergstrasse 50 4056 Basel Switzerland
1 shared publicationBlijke S. Kroezen
Molecular Pharmacy Group Department of Pharmaceutical Sciences University of Basel Klingelbergstrasse 50 4056 Basel Switzerland
1 shared publication
Latest Publications
- Open Access
- 3 August 2020
- Published by Wiley in ChemMedChem
- Vol. 15 (18) , 1706-1719
A Potent Mimetic of the Siglec‐8 Ligand 6’‐Sulfo‐Sialyl Lewisx
Siglecs are members of the immunoglobulin gene family containing sialic acid binding N‐terminal domains. Among them, Siglec‐8 is expressed on various cell types of the immune system such as eosinophils, mast cells and weakly on basophils. Cross‐linking of Siglec‐8 with monoclonal antibodies triggers apoptosis in eosinophils and inhibits degranulation of mast cells, making Siglec‐8 a promising target for the treatment of eosinophil‐ and mast cell‐associated diseases such as asthma. The tetrasaccharide 6’‐sulfo‐sialyl Lewisx has been identified as a specific Siglec‐8 ligand in glycan array screening. Here, we describe an extended study enlightening the pharmacophores of 6’‐sulfo‐sialyl Lewisx and the successful development of a high‐affinity mimetic. Retaining the neuraminic acid core, the introduction of a carbocyclic mimetic of the Gal moiety and a sulfonamide substituent in the 9‐position gave a 20‐fold improved binding affinity. Finally, the residence time, which usually is the Achilles tendon of carbohydrate/lectin interactions, could be improved.
- 3 August 2020
- Published by Wiley in ChemMedChem
- Vol. 15 (18) , 1706-1719
Open AccessA Potent Mimetic of the Siglec‐8 Ligand 6’‐Sulfo‐Sialyl Lewisx
Siglecs are members of the immunoglobulin gene family containing sialic acid binding N‐terminal domains. Among them, Siglec‐8 is expressed on various cell types of the immune system such as eosinophils, mast cells and weakly on basophils. Cross‐linking of Siglec‐8 with monoclonal antibodies triggers apoptosis in eosinophils and inhibits degranulation of mast cells, making Siglec‐8 a promising target for the treatment of eosinophil‐ and mast cell‐associated diseases such as asthma. The tetrasaccharide 6’‐sulfo‐sialyl Lewisx has been identified as a specific Siglec‐8 ligand in glycan array screening. Here, we describe an extended study enlightening the pharmacophores of 6’‐sulfo‐sialyl Lewisx and the successful development of a high‐affinity mimetic. Retaining the neuraminic acid core, the introduction of a carbocyclic mimetic of the Gal moiety and a sulfonamide substituent in the 9‐position gave a 20‐fold improved binding affinity. Finally, the residence time, which usually is the Achilles tendon of carbohydrate/lectin interactions, could be improved.
- Open Access
- 2 June 2016
- Published by Wiley in ChemBioChem
- Vol. 17 (11) , 1043
Back Cover: The Conformational Variability of FimH: Which Conformation Represents the Therapeutic Target? (ChemBioChem 11/2016)
- 2 June 2016
- Published by Wiley in ChemBioChem
- Vol. 17 (11) , 1043
Open AccessBack Cover: The Conformational Variability of FimH: Which Conformation Represents the Therapeutic Target? (ChemBioChem 11/2016)
- Open Access
- 9 December 2008
- Published by Wiley in ChemBioChem
- Vol. 9 (18) , 2941-2945
Consistent Bioactive Conformation of the Neu5Acα(2→3)Gal Epitope Upon Lectin Binding
- 9 December 2008
- Published by Wiley in ChemBioChem
- Vol. 9 (18) , 2941-2945
Open AccessConsistent Bioactive Conformation of the Neu5Acα(2→3)Gal Epitope Upon Lectin Binding
- 21 September 2005
- Published by Taylor & Francis
Carbohydrate Mimetics in Drug Discovery
- 1 December 2004
- Published by Elsevier in Carbohydrate Research
- Vol. 339 (18) , 2835-2840
Synthesis of aryl sialosides using Mitsunobu conditions
- 1 December 2004
- Published by Elsevier in Carbohydrate Research
- Vol. 339 (18) , 2835-2840
Synthesis of aryl sialosides using Mitsunobu conditions